Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Opening Keynote: The Future of Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Opening Keynote: The Future of Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
